CRISPR nanoparticles are the next big hope in Alzheimer’s disease treatments
Read now →Nearly 6 million Americans live with Alzheimer's disease without solid treatment options.
Nearly 6 million Americans live with Alzheimer's disease without solid treatment options.
Niche drugs may be good for companies, but that doesn't mean they'll reach sufferers
Centenarians were found to have almost double the amounts of REST in their neurons, as compared with those who only lived to their seventies
Programmable CRISPR-responsive smart materials, like DNA hydrogels, are much more likely to become game-changers in our lifetimes